Giant leiomyoma of esophagus.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 3773534)

Published in J Surg Oncol on November 01, 1986

Authors

M D Kramer, S P Gibb, F H Ellis

Articles by these authors

Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice. Proc Natl Acad Sci U S A (1990) 4.15

Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis (1993) 3.92

Recombinant outer surface protein a from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice. J Infect Dis (1991) 3.58

Molecular cloning and immunological characterization of a novel linear-plasmid-encoded gene, pG, of Borrelia burgdorferi expressed only in vivo. Infect Immun (1995) 3.00

The severe combined immunodeficiency (scid) mouse. A laboratory model for the analysis of Lyme arthritis and carditis. J Exp Med (1989) 2.68

Lyme borreliosis in the severe combined immunodeficiency (scid) mouse manifests predominantly in the joints, heart, and liver. Am J Pathol (1990) 2.15

Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. Am J Clin Pathol (1978) 2.13

Evaluation of genetic divergence among Borrelia burgdorferi isolates by use of OspA, fla, HSP60, and HSP70 gene probes. Infect Immun (1992) 2.10

The Borrelia burgdorferi flagellum-associated 41-kilodalton antigen (flagellin): molecular cloning, expression, and amplification of the gene. Infect Immun (1990) 2.10

The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients. Cancer Res (2000) 2.09

Analysis of the records of 1,657 patients with carcinoma of the esophagus and cardia of the stomach. Surg Gynecol Obstet (1970) 2.05

Effect of antireflux operation on Barrett's mucosa. Ann Thorac Surg (1990) 2.04

The spectrum of pulmonary sequestration. Ann Thorac Surg (1974) 2.03

Barrett's esophagus. Prevalence and incidence of adenocarcinoma. Arch Intern Med (1991) 2.01

Endoscopic surveillance of Barrett's esophagus. Does it help? J Thorac Cardiovasc Surg (1993) 2.00

Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma. Cancer Res (1998) 1.92

Esophagomyotomy for esophageal achalasia: experimental, clinical, and manometric aspects. Ann Surg (1967) 1.91

Distinct patterns of protective antibodies are generated against Borrelia burgdorferi in mice experimentally inoculated with high and low doses of antigen. Immunol Lett (1993) 1.84

Barrett's esophagus: congenital or acquired? An experimental study of esophageal mucosal regeneration in the dog. Surgery (1970) 1.80

Esophagogastrectomy for carcinoma: current hospital mortality and morbidity rates. Ann Surg (1979) 1.78

Paraesophageal hiatus hernia. Arch Surg (1986) 1.78

The outer surface protein A of the spirochete Borrelia burgdorferi is a plasmin(ogen) receptor. Proc Natl Acad Sci U S A (1994) 1.76

Experimental Borrelia burgdorferi infection in inbred mouse strains: antibody response and association of H-2 genes with resistance and susceptibility to development of arthritis. Eur J Immunol (1991) 1.71

Molecular and immunological characterization of a novel polymorphic lipoprotein of Borrelia burgdorferi. Infect Immun (1993) 1.64

Cloning and sequencing of the gene encoding the outer surface protein A (OspA) of a European Borrelia burgdorferi isolate. Nucleic Acids Res (1989) 1.53

A mouse model for Borrelia burgdorferi infection: approach to a vaccine against Lyme disease. Immunol Today (1991) 1.52

Molecular and biochemical characterization of a cytokinin oxidase from maize. Plant Physiol (2001) 1.52

Current concepts concerning the nature and treatment of Barrett's esophagus and its complications. Ann Thorac Surg (1992) 1.45

Cellular immune reactivity to recombinant OspA and flagellin from Borrelia burgdorferi in patients with Lyme borreliosis. Complexity of humoral and cellular immune responses. J Clin Invest (1992) 1.45

Syndrome of vigorous achalasia: Clinical and physiologic observations. Dis Chest (1967) 1.43

Paraesophageal hiatal hernia: is an antireflux procedure necessary? Ann Thorac Surg (1993) 1.39

Invited letter concerning: surgical treatment of carcinoma of the thoracic esophagus and cardia. J Thorac Cardiovasc Surg (1990) 1.39

Invited letter concerning: Long-term results of the Belsey Mark IV antireflux operation in relation to the severity of esophagitis. J Thorac Cardiovasc Surg (1990) 1.39

Achalasia and squamous cell carcinoma of the esophagus: analysis of 241 patients. Ann Thorac Surg (1995) 1.38

Immune sera to individual Borrelia burgdorferi isolates or recombinant OspA thereof protect SCID mice against infection with homologous strains but only partially or not at all against those of different OspA/OspB genotype. Vaccine (1993) 1.37

Plasminogen activator inhibitor-1 and prognosis in primary breast cancer. J Clin Oncol (1994) 1.36

The effect of fundoplication on the lower esophageal sphincter. Surg Gynecol Obstet (1976) 1.36

Coiling phagocytosis is the preferential phagocytic mechanism for Borrelia burgdorferi. Infect Immun (1992) 1.35

Identification of herpes simplex virus type 1 glycoproteins interacting with the cell surface. J Virol (1990) 1.34

An experimental study of the role of gastric and esophageal muscle in gastroesophageal competence. Surg Gynecol Obstet (1966) 1.27

Protection against Borrelia burgdorferi infection in SCID mice is conferred by presensitized spleen cells and partially by B but not T cells alone. Int Immunol (1994) 1.24

Differential immune responses to Borrelia burgdorferi in European wild rodent species influence spirochete transmission to Ixodes ricinus L. (Acari: Ixodidae). Infect Immun (1994) 1.24

Demonstration of antigen-specific T cells and histopathological alterations in mice experimentally inoculated with Borrelia burgdorferi. Infect Immun (1989) 1.24

Operation for esophageal achalasia. Results of esophagomyotomy without an antireflux operation. J Thorac Cardiovasc Surg (1984) 1.23

Acquired nonmalignant esophagotracheobronchial fistula. Report of 36 cases. JAMA (1966) 1.19

Detection of Borrelia burgdorferi sensu lato in lesional skin of patients with erythema migrans and acrodermatitis chronica atrophicans by ospA-specific PCR. J Clin Microbiol (1994) 1.18

Achalasia of the esophagus: results of therapy by dilation, 1950-1967. Chest (1970) 1.18

Systemic manifestations of gluten enteropathy. Med Clin North Am (1966) 1.17

Cricopharyngeal myotomy for pharyngo-esophageal diverticulum. Ann Surg (1969) 1.17

Reoperation for complications of the Nissen fundoplication. J Thorac Cardiovasc Surg (1981) 1.17

Molecular analysis of the outer surface protein A (OspA) of Borrelia burgdorferi for conserved and variable antibody binding domains. Med Microbiol Immunol (1992) 1.13

Adenocarcinoma in Barrett's esophagus. A clinicopathologic study of 65 cases. Ann Surg (1991) 1.13

Carcinoma of the esophagus: surgery versus radiotherapy. Postgrad Med (1977) 1.13

Achalasia of the esophagus in a small urban community. Mayo Clin Proc (1969) 1.13

Quality control of immunohistochemical evaluation of tumour-associated plasminogen activators and related components. European BIOMED-1 Concerted Action on Clinical Relevance of Proteases in Tumour Invasion and Metastasis. Eur J Cancer (1998) 1.13

Pulmonary venous infarction. Chest (1992) 1.12

Coronary artery aneurysm. Ann Thorac Surg (1978) 1.12

Esophagomyotomy for achalasia of the esophagus. Ann Surg (1980) 1.11

Postoperative prosthetic valve bacterial endocarditis due to Corynebacterium xerosis. Mayo Clin Proc (1967) 1.11

Primary adenocarcinoma of the esophagus: 18-year review and review of literature. Ann Surg (1966) 1.11

Characterization and isolation of a trypsin-like serine protease from a long-term culture cytolytic T cell line and its expression by functionally distinct T cells. J Immunol (1986) 1.11

Purification and characterization of a T cell specific serine proteinase (TSP-1) from cloned cytolytic T lymphocytes. EMBO J (1986) 1.10

Cervical esophageal dysphagia: indications for and results of cricopharyngeal myotomy. Ann Surg (1981) 1.10

Characterization of Borrelia burgdorferi isolated from different organs of Ixodes ricinus ticks collected in nature. Zentralbl Bakteriol (1994) 1.09

Esophagopleural fistula. A rare postpneumonectomy complication. Ann Thorac Surg (1969) 1.09

Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells. Int J Cancer (1985) 1.08

Endoscopic surveillance of Barrett's esophagus: a cost-effectiveness comparison with mammographic surveillance for breast cancer. Am J Gastroenterol (1998) 1.07

Esophageal function after successful repair of esophageal atresia and tracheoesophageal fistula. A manometric and cinefluorographic study. J Thorac Cardiovasc Surg (1968) 1.04

The experimental and clinical use of autogenous pericardium for the replacement and extension of mitral and tricuspid value cusps and chordae. J Cardiovasc Surg (Torino) (1965) 1.04

Replacement of the canine mitral valve with semilunar valves. J Thorac Cardiovasc Surg (1966) 1.03

Achalasia and carcinoma of the esophagus. JAMA (1971) 1.03

Selective use of myotomy for treatment of epiphrenic diverticula. Manometric and clinical analysis. Arch Surg (1992) 1.02

Cloned cytolytic T-effector cells and their malignant variants produce an extracellular matrix degrading trypsin-like serine proteinase. Immunology (1987) 1.02

Barrett's esophagus and associated adenocarcinoma in a mouse surgical model. J Surg Res (2000) 1.02

Primary mixed malignancies of lung: carcinosarcoma and blastoma. J Thorac Cardiovasc Surg (1969) 1.01

Adult dysphagia lusoria. Treatment by arterial division and reestablishment of vascular continuity. Chest (1985) 1.01

Lyme carditis in immunodeficient mice during experimental infection of Borrelia burgdorferi. Virchows Arch A Pathol Anat Histopathol (1990) 1.01

Upper esophageal sphincter in health and disease. Surg Clin North Am (1971) 0.99

External quality assessment of trans-European multicentre antigen determinations (enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) in human breast cancer tissue extracts. Br J Cancer (1998) 0.99

Ten to 20-year clinical results after short esophagomyotomy without an antireflux procedure (modified Heller operation) for esophageal achalasia. Eur J Cardiothorac Surg (1992) 0.99

Plasminogen activator inhibitor-2: prognostic relevance in 1012 patients with primary breast cancer. Cancer Res (1995) 0.99

Tick factors and in vitro cultivation influence the protein profile, antigenicity and pathogenicity of a cloned Borrelia garinii isolate from Ixodes ricinus hemolymph. Infection (1996) 0.99

Spinal cord injury after procedures on the aorta. Surg Gynecol Obstet (1972) 0.99

Anatomy of feline esophagus with special reference to its muscular wall and phrenoesophageal membrane. J Surg Res (1970) 0.98

Barrett's esophagus in a patient with achalasia. Am J Gastroenterol (1985) 0.98

Activation of pro-urokinase by the human T cell-associated serine proteinase HuTSP-1. FEBS Lett (1990) 0.97

Tumor necrosis factor-alpha-induced apoptosis in a human keratinocyte cell line (HaCaT) is counteracted by transforming growth factor-alpha. Exp Cell Res (1996) 0.97

Therapy with a purified plasminogen concentrate in an infant with ligneous conjunctivitis and homozygous plasminogen deficiency. N Engl J Med (1998) 0.96

Ventricular septal defect after myocardial infarction. Ann Intern Med (1969) 0.96

Fundoplication for gastroesophageal reflux. A comparison of preoperative and early postoperative manometric findings. Chest (1972) 0.96

Postventriculotomy aneurysm in patients with idiopathic hypertrophic subaortic stenosis. Am J Cardiol (1971) 0.95

Esophagogastrectomy. A safe, widely applicable, and expeditious form of palliation for patients with carcinoma of the esophagus and cardia. Ann Surg (1983) 0.95